In this newsletter, we are showcasing some of our product categories that help target the signalling pathways in viral infections and can be an essential tool in the R&D of antiviral therapies. It includes therapeutic targets for molecular and cellular pathways of the virus life cycle, along with the mechanism of action based treatment strategies. We hope you find this helpful and informative.
An adenosine nucleoside analogue that inhibits flavivirus and proliferation of EV71, which is one of the major causative agents of Hand-Foot-Mouth Disease.
